CELLINK appoints Carnegie Investment Bank AB (publ) as financial adviser

CELLINK and the board of directors have appointed Carnegie Investment Bank AB (publ) as financial adviser to explore a potential relisting of the Company’s shares to Nasdaq Stockholm’s main list and to evaluate other strategic and financial initiatives.

For further information, please contact:

Erik Gatenholm, CEO                                                     Gusten Danielsson, CFO

Phone: +46 73 267 00 00                                              Phone: +46 70 991 86 04

E-mail: [email protected]                                                  E-mail: [email protected]


CELLINK has created one of the world's first universal Bioinks, today used by many of the world's most well-reputed research institutions. A Bioink can be mixed with living cells to print functional human tissues and if future research is successful, eventually, complete human organs in so-called 3D-Bioprinters. CELLINK's universal Bioink shows excellent results and can be used in both CELLINK's proprietary 3D Bioprinters and in 3D Bioprinters developed by other operators.

Latest press releases